Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Not yet recruiting × NET × Clear all

Phase

Phase NA 5 Phase 2 3 Phase 4 1 Phase 1 1

Status

Completed 9 Recruiting 4 Unknown 2 Withdrawn 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 30 Breast 19 Lymphoid 12 Thoracic 11 Gynecologic 10 Plasma cell 7 Other hematologic neoplasm 7 Genitourinary 7 Classical hematology 6 Dermatologic 5 Head & Neck 4 Other 3 Endocrine 3 Myeloid 2 Sarcoma 1 Other solid neoplasm 1 NET 1 CNS 1

Conditions

Neuroendocrine Tumors 1

Interventions

Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06485739 2024-07-03

Irinotecan Liposomes for the Treatment of Neuroendocrine Carcinoma

First Affiliated Hospital Xi'an Jiaotong University

Phase 4 Not yet recruiting

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡